Physiology Department, Neuroscience Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran,
J Physiol Biochem. 2014 Jun;70(2):497-507. doi: 10.1007/s13105-014-0330-7. Epub 2014 Mar 19.
Opioid receptors play an important role in modulation of hyperalgesia in inflamed tissues, but chronic morphine application induces such side effects as tolerance. There is near communications between cytokines and mu opioid receptor expression. This study was aimed to assess the role of serum IL-10 in morphine tolerance development during adjuvant-induced arthritis. Adjuvant arthritis (AA) was induced on day 0 by single injection of Complete Freund's Adjuvant (CFA) into the rats' hindpaw. Hyperalgesia, edema, and spinal mu opioid receptor (mOR) variations were assessed on 0, 7, 14, and 21 days of the study. For assessment of the morphine tolerance development, morphine effective dose (4 mg/kg) was administered from the 14th day after CFA injection and continued until the morphine post-dose paw withdrawal latency (PWL); it did not significantly differ from the baseline. For assessment of the effects of IL-10 on tolerance induction, a neutralizing dose (ND50) of anti-IL-10 was administered daily during different stages of the study. AA induction in the right hindpaw of rats resulted in unilateral inflammation and hyperalgesia within 21 days of the study. Anti-IL-10 antibody administration in the AA rats induced marked elevation of hyperalgesia compared to the AA control group. Our data also indicated that morphine effective anti-hyperalgesic dose significantly decreased in the AA rats compared to the control group, which this symptom was aligned with spinal mu opioid receptor (mOR) expression increase during AA. Moreover, there was a significant difference in morphine tolerance induction between the AA and control rats, and our results also demonstrated that IL-10 played an important role in tolerance-induction process. It can be concluded that morphine tolerance slowly progressed when administered morphine effective dose was reduced during AA chronic inflammation. On the other hand, it seems that increased level of serum IL-10 may affect morphine tolerance development during inflammation.
阿片受体在调节炎症组织中的痛觉过敏中发挥重要作用,但慢性吗啡应用会引起耐受等副作用。细胞因子与μ阿片受体表达之间存在密切的通讯。本研究旨在评估血清 IL-10 在佐剂性关节炎(AA)中吗啡耐受发展中的作用。在第 0 天通过向大鼠后爪单次注射完全弗氏佐剂(CFA)诱导 AA。在研究的第 0、7、14 和 21 天评估痛觉过敏、水肿和脊髓 μ阿片受体(mOR)变化。为了评估吗啡耐受的发展,从 CFA 注射后第 14 天开始给予吗啡有效剂量(4mg/kg),并持续到吗啡后剂量的足底撤回潜伏期(PWL);它与基线相比没有显著差异。为了评估 IL-10 对诱导耐受的影响,在研究的不同阶段给予中和剂量(ND50)的抗 IL-10 抗体。AA 在大鼠右后爪的诱导导致单侧炎症和痛觉过敏在研究的 21 天内。与 AA 对照组相比,AA 大鼠中抗 IL-10 抗体的给药导致痛觉过敏明显升高。我们的数据还表明,与对照组相比,吗啡有效抗痛觉过敏剂量在 AA 大鼠中显著降低,这一症状与 AA 期间脊髓 μ阿片受体(mOR)表达增加相一致。此外,AA 大鼠和对照组大鼠之间的吗啡耐受诱导存在显著差异,我们的结果还表明,IL-10 在耐受诱导过程中发挥重要作用。可以得出结论,当在 AA 慢性炎症期间减少吗啡有效剂量时,吗啡耐受会缓慢进展。另一方面,似乎血清 IL-10 水平的升高可能会影响炎症期间的吗啡耐受发展。